Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul;11(7):4071-4073.
doi: 10.4103/jfmpc.jfmpc_2394_21. Epub 2022 Jul 22.

Small fiber neuropathy as a complication of SARS-CoV-2 vaccinations

Affiliations
Case Reports

Small fiber neuropathy as a complication of SARS-CoV-2 vaccinations

Josef Finsterer. J Family Med Prim Care. 2022 Jul.

Abstract

Generally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations are not free of side effects. A rarely reported adverse reaction to SARS-CoV-2 vaccinations is small fiber neuropathy (SFN). Here, we present three patients with SFN after the second dose of messenger ribonucleic acid-based SARS-CoV-2 vaccines. Data for this study were collected via the self-made platform "Pubbly" for reporting side effects of SARS-CoV-2 vaccinations. Three patients with post-SARS-CoV-2 vaccination SFN were identified: a 40 yo Caucasian female (patient 1), a 52 yo Caucasian female (patient 2), and a 32 yo Caucasian female (patient 3). Patient 1 complained about fatigue, dizziness, flushing, palpitations, diarrhea, muscle weakness, and gait disturbance 10 days after the second Pfizer jab. Patient 2 reported dizziness, balance problems, brain fog, palpitations, dysphagia, and sleep problems. Patient 3 complained about profound fatigue, brain fog, vertigo, pre-syncopal sensations, hair loss, chest pain, dyspnea, palpitations, paresthesias, irregular menstrual cycles, muscle weakness, and hives 1 day after the second Moderna dose. All three patients underwent skin biopsy upon which SFN was diagnosed. Patient 1 profited from immunoglobulins, but patient 2 did not require any treatment. Symptoms in patient 3 resolved upon symptomatic treatment. Despite treatment, patient 1 did not completely recover. SFN can be a rare side effect of SARS-CoV-2 vaccinations. Post-SARS-CoV-2 vaccination SFN can be mild or severe and may or may not require treatment. Post-SARS-CoV-2 vaccination SFN is most likely immune-mediated as it responds to intravenous immunoglobulins.

Keywords: Adverse reaction; COVID-19; SARS-CoV-2; neuropathy; pain; side effect; small fibers; vaccination.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Gibbons CH. Small fiber neuropathies. Continuum (Minneap Minn) 2014;20 (5 Peripheral Nervous System Disorders):1398-412. - PubMed
    1. Contijoch Roqueta C, Izquierdo MF, Arrabal Solano L. Neuropatía de fibras pequeñas:Una revisión small fibre neuropathy:A review. Semergen. 2020;46:277–82. - PubMed
    1. Egenolf N, Zu Altenschildesche CM, Kreß L, Eggermann K, Namer B, Gross F, et al. Diagnosing small fiber neuropathy in clinical practice:A deep phenotyping study. Ther Adv Neurol Disord. 2021;14:17562864211004318. - PMC - PubMed
    1. Consonni M, Telesca A, Grazzi L, Cazzato D, Lauria G. Life with chronic pain during COVID-19 lockdown:The case of patients with small fibre neuropathy and chronic migraine. Neurol Sci. 2021;42:389–7. - PMC - PubMed
    1. Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, et al. Autonomic dysfunction following COVID-19 infection:An early experience. Clin Auton Res. 2021;31:385–94. - PMC - PubMed

Publication types